Skip to Content Facebook Feature Image

Biogénesis Bagó opens offices in Vietnam, strengthening its presence in Asia

Business

Biogénesis Bagó opens offices in Vietnam, strengthening its presence in Asia
Business

Business

Biogénesis Bagó opens offices in Vietnam, strengthening its presence in Asia

2024-12-03 23:34 Last Updated At:23:55

After years of commitment to animal health in the Asian market providing high-quality biotechnological solutions, this significant milestone further strengthens the company's long-term expansion strategy in the region. This is also reinforced by the recent launch of the FMD vaccine, Bioaftogen, in Thailand and Indonesia

HO CHI MINH, Vietnam, Dec. 3, 2024 /PRNewswire/ -- With the presence of local authorities and partners from Vietnam, Thailand, and South Korea, Biogénesis Bagó inaugurated its offices in Vietnam, a dedicated space to grow their team and foster closer relationships with clients and partners.

This opening of the regional offices in Vietnam will provide the ability to work collaboratively toward continued expansion in a market where Biogénesis Bagó sees immense potential and opportunities to make a meaningful impact on animal health in the region.

"Having a local base in Vietnam allows us to better understand the specific needs of our clients and respond with tailored biotechnological solutions that address their challenges. This expansion represents a key step in our ongoing mission to support and enhance animal health across Asia, a market we are confident will continue to offer significant growth opportunities," said the CEO of Biogenesis Bago, Mr. Esteban Turic.

The biotechnological company currently has production sites in China and South Korea through key partnerships, as well as technical and commercial teams' representatives in different markets across the region. Last October, their FMD vaccine, Bioaftogen, was launched in the Thai market in collaboration with their partners CVG Tech and Advance Pharma, as well as in the Indonesian market, in November, together with Elanco. This ensures a high-quality solution that will protect animal health, enabling livestock producers to increase productivity and achieve better results.

Asia is an extremely important market for Biogénesis Bagó. The company expects to continue developing the business in different countries in the region, in order to boost productivity and contribute to guaranteeing the animal health status and food security of the region.

About Biogénesis Bagó is a global biotechnology company that leads in the health, productivity, and animal welfare sector. The company develops, produces, and markets world-class products for the protection of countries' health statuses and plays a key role in the prevention of zoonotic diseases, as well as in food production safety. It is a reference for the prevention and control of foot-and-mouth disease and one of the main producers of the canine rabies vaccine, being able to respond to health emergencies immediately anywhere in the world.

Press Contact

BOND Communications

Florencia Bonnin | flor@prbond.com 
Mercedes García Bartelt | mercedes@prbond.com

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Biogénesis Bagó opens offices in Vietnam, strengthening its presence in Asia

Biogénesis Bagó opens offices in Vietnam, strengthening its presence in Asia

Over 11.6 million risky driving events recorded across 3.6 billion kilometres of travel in 12 months

CANBERRA, Australia, Dec. 4, 2024 /PRNewswire/ -- Seeing Machines Limited (AIM: SEE), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, announces the release of its 2023-24 Guardian Insights Report. The insights are drawn from de-identified data collected from the company's leading driver fatigue and distraction solution, Guardian, aimed at commercial transport and logistics fleets, and scientifically proven to reduce fatigue related driving events by more than 90%.

The report takes information from over 60,000 vehicles and now covers all major global regions. Leveraging Seeing Machines' unparalleled, naturalistic driving data to pinpoint and address the trends surrounding risky driving habits, the report provides unique, critical insights into the challenges of driver fatigue and distraction worldwide, and underscores the urgent need for targeted, data-driven safety measures. 

At a glance, Guardian captured a staggering 11.6 million risky driving events across fleets globally, as confirmed by human analysts in the 24/7 Guardian Centre. This included over 450,000 fatigue events and more than 2.7 million distracted driving events, with at least 23% of these being attributed to mobile phone use.  

"Driver distraction and fatigue continue to contribute significantly to road fatalities and injuries worldwide," said Max Verberne, General Manager – Aftermarket, Seeing Machines. "This report not only highlights the scale of the issue but also provides actionable insights to help fleets mitigate the risks relating to driver impairment, reducing road accidents and protecting lives." 

The report also provides regional comparisons, noting, for example, that Latin America accounts for nearly half of all distraction events globally, while the UK has the lowest rate of mobile phone distractions. These insights reflect the diverse challenges faced by fleets in different operating environments. 

The Guardian Insights Report further demonstrates Seeing Machines' commitment to its mission of zero transport fatalities. The Company invites fleet managers, policymakers and safety advocates to explore the report and join the global effort to improve road safety.

The full report is attached.

About Seeing Machines (LSE: SEE)

Seeing Machines is a global company founded in 2000 and headquartered in Australia, is an industry leader in vision-based monitoring technology that enable machines to see, understand and assist people. Seeing Machines is revolutionising global transport safety. Its technology portfolio of AI algorithms, embedded processing and optics, power products that need to deliver reliable real-time understanding of vehicle operators. The technology spans the critical measurement of where a driver is looking, through to classification of their cognitive state as it applies to accident risk. Reliable "driver state" measurement is the end-goal of Driver Monitoring Systems (DMS) technology. Seeing Machines develops DMS technology to drive safety for Automotive, Commercial Fleet, Off-road and Aviation. The company has offices in Australia, USA, Europe and Asia, and supplies technology solutions and services to industry leaders in each market vertical. www.seeingmachines.com

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Seeing Machines releases the 2023-24 Guardian Insights Report, highlighting alarming trends in driver fatigue and distraction from around the world

Seeing Machines releases the 2023-24 Guardian Insights Report, highlighting alarming trends in driver fatigue and distraction from around the world

Recommended Articles